Flavonoids as Multi-target Inhibitors for Proteins Associated with Ebola Virus: In Silico Discovery Using Virtual Screening and Molecular Docking Studies
- 2.1k Downloads
Ebola virus is a single-stranded, negative-sense RNA virus that causes severe hemorrhagic fever in humans and non-human primates. This virus is unreceptive to a large portion of the known antiviral drugs, and there is no valid treatment as on date for disease created by this pathogen. Looking into its ability to create a pandemic scenario across globe, there is an utmost need for new drugs and therapy to combat this life-threatening infection. The current study deals with the evaluation of the inhibitory activity of flavonoids against the four selected Ebola virus receptor proteins, using in silico studies. The viral proteins VP40, VP35, VP30 and VP24 were docked with small molecules obtained from flavonoid class and its derivatives and evaluated on the basis of energetics, stereochemical considerations and pharmacokinetic properties to identify potential lead compounds. The results showed that both top-ranking screened flavonoids, i.e., Gossypetin and Taxifolin, showed better docking scores and binding energies in all the EBOV receptors when compared to those of the reported compound. All the screened flavonoids have known antiviral activity, acceptable pharmacokinetic properties and are being used on human and thus can be taken as anti-Ebola therapy without the time lag for clinical trial.
KeywordsEbola virus Docking Virtual screening Flavonoids Pharmacokinetic Gossypetin Taxifolin
Compliance with Ethical Standards
Conflict of interest
We declare that we have no conflict of interest.
- 4.International Commission (1978) Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56(2):271–293Google Scholar
- 5.Hartlieb B, Modrof J, Mühlberger E, Klenk HD, Becker S (2003) Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. J BiolChem 278:41830–41836Google Scholar
- 11.Nanbo A, Watanabe S, Halfmann P, Kawaoka Y (2013) The spatio-temporal distribution dynamics of Ebola virus proteins and RNA in infected cells. Nature 10:1038Google Scholar
- 19.Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y (2007) Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J Infect Dis 196Google Scholar
- 24.Rajamani R, Good AC (2007) Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development. Curr Opin Drug Discov Dev 10:308–315Google Scholar
- 34.Shaw DE, Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO (2010) Improved side-chain torsion potentials for the amber ff99SB protein force field. Proteins: Struct Funct Bioinform 78(8):1950–1958Google Scholar
- 35.Mounnissamy VM, Kavimani S, Gunasegaran R (2002) Antibacterial activity of gossypetin isolated from hibiscus sabdariffa. Antiseptic 99(3):81–82Google Scholar
- 36.Todorov D, Hinkov A, Shishkova K, Shishkov S (2014) Antiviral potential of Bulgarian medicinal plants. Phytochem Rev 014-9357-1Google Scholar
- 38.Shi Q, Li C, Huo C, Zhang M (2007) Chemistry of Chinese yew, Taxus chinensis var. mairei. Biochem Syst Ecol 36(4):266–282Google Scholar